Vanguard Group
GYRE icon

Vanguard Group’s Gyre Therapeutics GYRE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.45M Buy
1,149,709
+53,221
+5% +$391K ﹤0.01% 2995
2025
Q1
$8.46M Buy
1,096,488
+774,024
+240% +$5.98M ﹤0.01% 2935
2024
Q4
$3.9M Sell
322,464
-17,707
-5% -$214K ﹤0.01% 3362
2024
Q3
$4.27M Buy
340,171
+108,530
+47% +$1.36M ﹤0.01% 3327
2024
Q2
$2.76M Buy
231,641
+36,543
+19% +$436K ﹤0.01% 3463
2024
Q1
$3.41M Sell
195,098
-2,999
-2% -$52.4K ﹤0.01% 3431
2023
Q4
$5.09M Sell
198,097
-8,803
-4% -$226K ﹤0.01% 3279
2023
Q3
$99.8K Buy
+206,900
New +$99.8K ﹤0.01% 4348
2023
Q1
Sell
-1,335,746
Closed -$705K 4560
2022
Q4
$705K Sell
1,335,746
-37,266
-3% -$19.7K ﹤0.01% 4015
2022
Q3
$692K Hold
1,373,012
﹤0.01% 4115
2022
Q2
$2.44M Sell
1,373,012
-20,500
-1% -$36.5K ﹤0.01% 3722
2022
Q1
$920K Hold
1,393,512
﹤0.01% 4234
2021
Q4
$1.27M Sell
1,393,512
-29,870
-2% -$27.3K ﹤0.01% 4195
2021
Q3
$5.85M Buy
1,423,382
+1,051
+0.1% +$4.32K ﹤0.01% 3553
2021
Q2
$6.16M Sell
1,422,331
-110,614
-7% -$479K ﹤0.01% 3480
2021
Q1
$7.73M Buy
1,532,945
+550,542
+56% +$2.78M ﹤0.01% 3300
2020
Q4
$6.2M Buy
982,403
+63,976
+7% +$404K ﹤0.01% 3256
2020
Q3
$3.95M Sell
918,427
-17,635
-2% -$75.8K ﹤0.01% 3272
2020
Q2
$5.49M Buy
936,062
+270,763
+41% +$1.59M ﹤0.01% 3055
2020
Q1
$2.91M Buy
665,299
+62,002
+10% +$271K ﹤0.01% 3192
2019
Q4
$4.11M Hold
603,297
﹤0.01% 3229
2019
Q3
$2.96M Buy
603,297
+11,258
+2% +$55.3K ﹤0.01% 3312
2019
Q2
$4.36M Buy
592,039
+33,504
+6% +$247K ﹤0.01% 3216
2019
Q1
$4.53M Buy
558,535
+316,659
+131% +$2.57M ﹤0.01% 3172
2018
Q4
$1.91M Sell
241,876
-309,808
-56% -$2.44M ﹤0.01% 3393
2018
Q3
$5.95M Sell
551,684
-2,453
-0.4% -$26.4K ﹤0.01% 3166
2018
Q2
$6.47M Buy
554,137
+183,534
+50% +$2.14M ﹤0.01% 3112
2018
Q1
$9.56M Buy
370,603
+277,451
+298% +$7.16M ﹤0.01% 2843
2017
Q4
$1.27M Buy
93,152
+35,785
+62% +$488K ﹤0.01% 3551
2017
Q3
$289K Buy
57,367
+13,653
+31% +$68.8K ﹤0.01% 3848
2017
Q2
$204K Buy
43,714
+32,621
+294% +$152K ﹤0.01% 3900
2017
Q1
$104K Sell
11,093
-92,422
-89% -$866K ﹤0.01% 3985
2016
Q4
$67K Sell
103,515
-102,198
-50% -$66.1K ﹤0.01% 4006
2016
Q3
$249K Sell
205,713
-35,399
-15% -$42.8K ﹤0.01% 3866
2016
Q2
$367K Hold
241,112
﹤0.01% 3842
2016
Q1
$405K Buy
241,112
+147
+0.1% +$247 ﹤0.01% 3832
2015
Q4
$754K Buy
240,965
+30,738
+15% +$96.2K ﹤0.01% 3710
2015
Q3
$980K Sell
210,227
-1,097,312
-84% -$5.12M ﹤0.01% 3641
2015
Q2
$3.65M Sell
1,307,539
-486,493
-27% -$1.36M ﹤0.01% 3157
2015
Q1
$5.33M Buy
1,794,032
+84,333
+5% +$251K ﹤0.01% 2969
2014
Q4
$4.5M Buy
1,709,699
+636,781
+59% +$1.67M ﹤0.01% 2954
2014
Q3
$2.72M Buy
1,072,918
+99,877
+10% +$253K ﹤0.01% 3134
2014
Q2
$4.39M Sell
973,041
-29,749
-3% -$134K ﹤0.01% 2905
2014
Q1
$4.76M Buy
1,002,790
+85,741
+9% +$407K ﹤0.01% 2855
2013
Q4
$3.81M Buy
917,049
+72,432
+9% +$301K ﹤0.01% 2932
2013
Q3
$4.49M Buy
844,617
+12,582
+2% +$66.8K ﹤0.01% 2801
2013
Q2
$3.55M Buy
+832,035
New +$3.55M ﹤0.01% 2850